GLP-1 Drugs Used to Reduce Cancer, Fight Dementia
GLP-1 agonists such as Ozempic and Wegovy are being tested for their ability to impact cancer rates and slow dementia.
The Movement Away From Abstinence and Toward Addiction Resistance
The unrealistic focus of substance abuse education on abstinence is yielding to a more enlightened approach based on addiction resistance.
Can Addiction Be Treated With Low-Intensity Focused Ultrasound?
The Wellcome Leap fund for Untangling Addiction has awarded $50 million in financing for 14 projects including low-intensity focused ultrasound (LIFU).
Investigative Journalist Takes a Hard Look at California’s Addiction Treatment Programs
Watchdog Columnist Teri Sforza attends ASAM55 and comes away with a few suggestions for California Governor Gavin Newsom.
More Studies Show Positive Impacts From GLP-1 Agonist Drugs
A new survey from National Geographic explores many positive outcomes of recent trials with GLP-1 agonist drugs.
The Community Reinforcement Approach for Substance Use Disorders
Developed in the 1970s and refined in the 1990s, the Community Reinforcement Approach (CRA) is inexpensive and effective.